Journal Oncology Times
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Slows Progression in Refractory HER2+ Breast Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0420Published: April 2020Expires: 3/4/2022Sources: Oncology TimesDetailsPassing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Antibody Drug Conjugates: New Weapons Against Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0320Published: March 2020Expires: 3/4/2022Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Categories: Advanced Practice Nursing , OncologySpecialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Where Do the Recommendations for HPV Vaccination Stand?
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0220BPublished: February 2020Expires: 12/3/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Categories: Advanced Practice Nursing , OncologySpecialties: Advanced Practice Nursing, OncologyTopics: Human Papillomavirus (HPV) , Vaccinations -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Data reports Largest Ever 1-year Drop in U.S. Cancer Deaths
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0220APublished: February 2020Expires: 12/3/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Study Tracks Accelerating Use of Biomarkers in Cancer Clinical Trials
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1219Published: December 2019Expires: 12/3/2021Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Driving Change in Small Bowel Adenocarcinoma
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1119Published: November 2019Expires: 9/3/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Management of Tyrosine Kinase Inhibitor Anticancer Agents with Gastric Acid Suppression Medications
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1019Published: October 2019Expires: 9/3/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Specialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Relevant Biomarkers for the Treatment of Hematological Malignancies
Price: $10.00Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0919Published: September 2019Expires: 6/3/2021Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ASCO Guidelines Direct Clinical Decisions for Biliary Tract Cancer
Price: $10.00Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0819Published: August 2019Expires: 6/4/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)Specialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Potential of Psilocybin Administration in Terminal Cancer Patients
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0719Published: Jul 2019Expires: 6/4/2021Sources: Oncology TimesDetailsPassing Score: 7/10 (70%)